Cargando…
Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843481/ https://www.ncbi.nlm.nih.gov/pubmed/32949301 http://dx.doi.org/10.1007/s00417-020-04930-2 |
_version_ | 1783644155062255616 |
---|---|
author | Terheyden, Laura Roider, Johann Klettner, Alexa |
author_facet | Terheyden, Laura Roider, Johann Klettner, Alexa |
author_sort | Terheyden, Laura |
collection | PubMed |
description | PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells and RPE/choroid explant cells under basolateral stimulation of TLR2, 3, and 4; the effects on barrier function; and their influence on neuronal cell viability. METHODS: RPE/choroid tissue explants were prepared from porcine eyes and cultivated in modified Ussing chambers; primary porcine RPE cells on transwell plates. Cells were basally stimulated with agonists Pam2CSK4 (Pam; TLR2), polyinosinic/polycytidylic acid (Poly I:C; TLR3), and lipopolysaccharide (LPS; TLR4) for 24 h. Supernatants were evaluated with ELISA for cytokines TNFα, IL-6, and IL-1β. Apical supernatants were applied to SHSY-5Y cells, and cell viability was evaluated in MTT assay. Barrier function was tested by measuring transepithelial electrical resistance (TER) and occludin immunostaining. RESULTS: None of the tested TLR agonists was toxic on RPE cells after 24 h of exposure. Unstimulated RPE cells secreted hardly any cytokines. Pam induced IL-6, IL-1ß, and TNFα on the basal and apical sides at all concentrations tested. Poly I:C induced IL-6 and TNFα primarily at the basal side at lower but on both sides at higher concentrations. LPS induced IL-6, IL-1ß, and TNFα apically and basally at all concentrations tested. In the RPE/choroid, a strong difference between apical and basal secretions could be found. IL-6 was constitutively secreted basally, but not apically, but was induced by all agonists on both sides. IL-1ß and TNFα alpha were strongly induced on the basal side by all agonists. TER was reduced by all agonists, with Pam and LPS being effective in all concentrations tested. Occludin expression was unaltered, but the distribution was influenced by the agonists, with a less distinct localization at the cell borders after treatment. None of the agonists or supernatants of treated RPE and RPE/choroid organ cultures exerted any effect on viability of SHSY-5Y cells. CONCLUSIONS: Danger signals activating TLRs can induce polarized cytokine expression and contribute to the loss of barrier function in the RPE. |
format | Online Article Text |
id | pubmed-7843481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78434812021-02-04 Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro Terheyden, Laura Roider, Johann Klettner, Alexa Graefes Arch Clin Exp Ophthalmol Basic Science PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells and RPE/choroid explant cells under basolateral stimulation of TLR2, 3, and 4; the effects on barrier function; and their influence on neuronal cell viability. METHODS: RPE/choroid tissue explants were prepared from porcine eyes and cultivated in modified Ussing chambers; primary porcine RPE cells on transwell plates. Cells were basally stimulated with agonists Pam2CSK4 (Pam; TLR2), polyinosinic/polycytidylic acid (Poly I:C; TLR3), and lipopolysaccharide (LPS; TLR4) for 24 h. Supernatants were evaluated with ELISA for cytokines TNFα, IL-6, and IL-1β. Apical supernatants were applied to SHSY-5Y cells, and cell viability was evaluated in MTT assay. Barrier function was tested by measuring transepithelial electrical resistance (TER) and occludin immunostaining. RESULTS: None of the tested TLR agonists was toxic on RPE cells after 24 h of exposure. Unstimulated RPE cells secreted hardly any cytokines. Pam induced IL-6, IL-1ß, and TNFα on the basal and apical sides at all concentrations tested. Poly I:C induced IL-6 and TNFα primarily at the basal side at lower but on both sides at higher concentrations. LPS induced IL-6, IL-1ß, and TNFα apically and basally at all concentrations tested. In the RPE/choroid, a strong difference between apical and basal secretions could be found. IL-6 was constitutively secreted basally, but not apically, but was induced by all agonists on both sides. IL-1ß and TNFα alpha were strongly induced on the basal side by all agonists. TER was reduced by all agonists, with Pam and LPS being effective in all concentrations tested. Occludin expression was unaltered, but the distribution was influenced by the agonists, with a less distinct localization at the cell borders after treatment. None of the agonists or supernatants of treated RPE and RPE/choroid organ cultures exerted any effect on viability of SHSY-5Y cells. CONCLUSIONS: Danger signals activating TLRs can induce polarized cytokine expression and contribute to the loss of barrier function in the RPE. Springer Berlin Heidelberg 2020-09-19 2021 /pmc/articles/PMC7843481/ /pubmed/32949301 http://dx.doi.org/10.1007/s00417-020-04930-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Basic Science Terheyden, Laura Roider, Johann Klettner, Alexa Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title | Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title_full | Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title_fullStr | Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title_full_unstemmed | Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title_short | Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro |
title_sort | basolateral activation with tlr agonists induces polarized cytokine release and reduces barrier function in rpe in vitro |
topic | Basic Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843481/ https://www.ncbi.nlm.nih.gov/pubmed/32949301 http://dx.doi.org/10.1007/s00417-020-04930-2 |
work_keys_str_mv | AT terheydenlaura basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro AT roiderjohann basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro AT klettneralexa basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro |